BZAM Ltd (BZAMF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
BZAM EPS Diluted (Quarterly): -0.0671 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0626 |
| June 30, 2023 | -0.2974 |
| March 31, 2023 | -0.0887 |
| December 31, 2022 | -0.0392 |
| September 30, 2022 | -0.007 |
| June 30, 2022 | -0.0704 |
| March 31, 2022 | -0.142 |
| December 31, 2021 | -0.0555 |
| September 30, 2021 | -0.2382 |
| June 30, 2021 | -0.4886 |
| March 31, 2021 | 0.1578 |
| December 31, 2020 | -0.3069 |
| September 30, 2020 | -1.501 |
| June 30, 2020 | -0.2164 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.715 |
| December 31, 2019 | -3.939 |
| September 30, 2019 | -0.5299 |
| June 30, 2019 | -0.4483 |
| March 31, 2019 | -0.3759 |
| December 31, 2018 | -0.605 |
| September 30, 2018 | -0.306 |
| June 30, 2018 | -0.31 |
| March 31, 2018 | -0.228 |
| December 31, 2017 | -0.1957 |
| September 30, 2017 | -0.0759 |
| June 30, 2017 | -0.0703 |
| March 31, 2017 | -0.0715 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-3.939
Minimum
Dec 2019
0.1578
Maximum
Mar 2021
-0.5631
Average
-0.1792
Median
EPS Diluted (Quarterly) Benchmarks
| Medical International Technology Inc | -- |
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -0.0152 |
| The Flowr Corp | -0.0077 |
| Canntab Therapeutics Ltd | -0.0074 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.67M |
| Revenue (Quarterly) | 15.68M |
| Total Expenses (Quarterly) | 25.31M |